BC Week In Review | Sep 7, 2009
Clinical News

Astepro azelastine HCL Nasal Spray 0 regulatory update

Meda said FDA approved an NDA for Astepro azelastine HCL Nasal Spray to treat seasonal and perennial allergic rhinitis in patients aged 12 and older. The company plans to launch the metered-dose solution of the...
Items per page:
1 - 1 of 1